BioSpace News Archive

Agendia Inc., a world leader in precision oncology for breast cancer, announced that the Federal Joint Committee has approved MammaPrint®, Agendia’s 70-Gene Breast Cancer Recurrence Assay.

CureLab Oncology, a clinical-stage pre-IPO biotech company, has commenced operations in the GCC region.

New supercomputer, for the European High Performance Computing Joint Undertaking initiative, will use HPE Cray EX supercomputers to power a theoretical peak performance of more than 550 petaflops

TLC, a clinical-stage, specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced the appointment of Thomas H. Bliss, Jr., MBA, as the Company’s Chief Business Officer following the retirement of Wenji Chen, PhD, MBA, from her position as Vice President of Corporate Development.

Nordic Nanovector ASA announces that an extraordinary general meeting in the Company was held at the Company’s offices in Kjelsåsveien 168B, 0884 Oslo.

United Therapeutics Corporation announced that it will report its third quarter 2020 financial results before the market opens on Wednesday, October 28, 2020.

n, a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced that it will present two poster presentations covering AT-007 in Galactosemia at the upcoming American Society of Human Genetics 2020 Annual Meeting.

PTG-300 was previously granted orphan drug designation by the U.S. Food and Drug Administration

Accessible 3D Single-Molecule Localization Microscopy for Studying Subcellular Organelles and Spatial Multiomics

ConfirmDx-Melanoma is Castle’s gene expression profile test for suspicious pigmented lesions